However, although the exact ratio between procathepsins and cathepsins in breast cancer is unknown, it can be rationalized that a major part of the increased expression levels can be attributed to active cathepsins, as cancer cells upregulate cathepsin expression to facilitate protein turnover and to degrade the extracellular-matrix [14]. The gene discussed is CTSS; the disease is breast cancer.